Suppr超能文献

通过雌激素受体α的非基因组作用诱导乳腺癌细胞中芳香化酶(CYP19)的表达。

Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.

作者信息

Kinoshita Yoshiyuki, Chen Shiuan

机构信息

Department of Surgical Research, Beckman Research Institute of the City of Hope, Duarte, California 91010, USA.

出版信息

Cancer Res. 2003 Jul 1;63(13):3546-55.

Abstract

Aromatase plays a critical role in breast cancer development by converting androgen to estrogen. In this report, results are presented to demonstrate that estrogen, the product of aromatase, can up-regulate its expression. Estrogen receptor (ER) transient transfection experiments were performed using the SK-BR-3 breast cancer cell line, which is ER negative and expresses aromatase. When SK-BR-3 cells were transfected with the expression plasmid pCI-ER alpha, but not pCI-ER beta, aromatase activity was elevated by 17beta-estradiol (E(2)) in a dose-dependent manner. The E(2) induction could be enhanced by cotransfection with the coactivator GRIP1 and suppressed by antiestrogens such as tamoxifen and ICI 182,780. The aromatase activity in the ER alpha-transfected SK-BR-3 cells could also be induced by environmental chemicals that were known to have an estrogen-like activity. Using aromatase gene exon Is-specific reverse transcription-PCR, the level of promoter I.1-driven transcripts was found to be elevated in E(2)-treated ER alpha-transfected cells. This suggested that E(2) induced aromatase expression through the up-regulation of promoter I.1. Using DNA deletion analysis of the 5'-flanking region of promoter I.1, the section between -300 and -280 bp upstream from exon I.1 was identified to be important for mediating E(2) induction. However, a direct binding of ER alpha to this 20-bp region could not be demonstrated. It was found that E(2) induction could be suppressed by the mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor, PD98059, and the epidermal growth factor receptor tyrosine kinase inhibitor, PD153035 hydrochloride. A significant induction of aromatase expression was also detected in ER-positive MCF-7 breast cancer cells after transfection with pCI-ER alpha and E(2) treatment. Furthermore, after ER alpha transfection and E(2) treatment, the aromatase activity in Her-2-overexpressing MCF-7 cells was drastically higher than that of the wild-type MCF-7 cells. In addition, aromatase induction in MCF-7 cells could also be suppressed by PD153035 hydrochloride. These results suggest that E(2) up-regulates aromatase expression by a nongenomic action of ER alpha via cross-talk with growth factor-mediated pathways.

摘要

芳香化酶通过将雄激素转化为雌激素在乳腺癌发展中起关键作用。在本报告中,展示的结果表明芳香化酶的产物雌激素可上调其表达。使用SK-BR-3乳腺癌细胞系进行雌激素受体(ER)瞬时转染实验,该细胞系ER阴性且表达芳香化酶。当用表达质粒pCI-ERα而非pCI-ERβ转染SK-BR-3细胞时,17β-雌二醇(E₂)以剂量依赖方式提高芳香化酶活性。与共激活剂GRIP1共转染可增强E₂诱导作用,而他莫昔芬和ICI 182,780等抗雌激素可抑制该作用。已知具有雌激素样活性的环境化学物质也可诱导ERα转染的SK-BR-3细胞中的芳香化酶活性。使用芳香化酶基因外显子I特异性逆转录PCR,发现启动子I.1驱动的转录本水平在E₂处理的ERα转染细胞中升高。这表明E₂通过上调启动子I.1诱导芳香化酶表达。通过对启动子I.1的5'侧翼区域进行DNA缺失分析,确定外显子I.1上游-300至-280 bp之间的区域对于介导E₂诱导很重要。然而,未证明ERα与该20 bp区域直接结合。发现丝裂原活化蛋白/细胞外信号调节激酶激酶抑制剂PD98059和表皮生长因子受体酪氨酸激酶抑制剂盐酸PD153035可抑制E₂诱导作用。在用pCI-ERα转染并经E₂处理的ER阳性MCF-7乳腺癌细胞中也检测到芳香化酶表达的显著诱导。此外,在ERα转染并经E₂处理后,HER-2过表达的MCF-7细胞中的芳香化酶活性明显高于野生型MCF-7细胞。此外,盐酸PD153035也可抑制MCF-7细胞中的芳香化酶诱导。这些结果表明E₂通过ERα的非基因组作用,经由与生长因子介导的途径相互作用上调芳香化酶表达。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验